Navigation Links
Martek Announces First Quarter 2009 Financial Results
Date:3/4/2009

-6; and granulocyte monocyte-colony stimulating factor. There was a corresponding increase in the concentration of anti-inflammatory matrix metalloproteinase. The authors noted that the reduction of CRP was similar to that seen with statins. Overall, the authors concluded that supplemental DHA may lessen the inflammatory response. Martek's life'sDHA(TM) was used in this study.

Financial Guidance

Martek expects total revenues for the second quarter of fiscal 2009 to be between $87 million and $92 million with second quarter infant formula revenue projected to be between $76 million and $80 million and second quarter non-infant formula nutritional revenue projected to be between $7 million and $9 million. Second quarter gross margin is expected to be approximately 42.5%. Net income for the second quarter is projected to be between $8.9 million and $10.3 million, and diluted earnings per share are projected to be between $0.27 and $0.31.

For the full fiscal year 2009, consistent with previous guidance, the Company continues to expect moderate growth of both revenues and profitability over fiscal 2008 with profitability continuing to grow at a higher rate than revenues primarily due to improvements in gross profit margins. However, if the current worldwide economic recession remains deep and prolonged, there is greater uncertainty with respect to the Company's ability to attain its forecasted operating results.

Investor Conference Call Webcast

Martek will host a conference call and Webcast for investors to review its first quarter results and fiscal 2009 outlook at 4:45 p.m. Eastern Time on Wednesday, March 4, 2009. Access to the live audio Webcast is available through Martek's website at http://investors.martek.com. The webcast will be available
'/>"/>

SOURCE Martek Biosciences Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Martek, General Mills Collaborate on Microencapsulation Technology for Food Applications
2. Martek to Present at 11th Annual ICR XChange
3. Martek to Present at Upcoming Needham Conference
4. Martek Announces Fourth Quarter and FY 2008 Financial Results
5. Martek to Announce Fourth Quarter and Fiscal Year 2008 Results
6. Frost & Sullivan Recognizes Martek Biosciences for Unique and Customer-Focused Strategies With Customer Value Enhancement Award
7. Martek to Present at Upcoming Canaccord Adams Conference
8. Martek to be the Sole Source Supplier of DHA and ARA for Infant Formulas Produced By Grupo Ricap
9. Martek is Now the Sole-Source Supplier of ARA for all Infant Formula Products Manufactured by Hochdorf Nutricare
10. Martek Signs Multi-Year Sole-Source Supply Agreement With Hero
11. Martek Announces Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 10, 2014  Franciscan St. Anthony ... capnography for respiratory monitoring outside the operating ... leaders in embracing state-of-the-art patient safety technology. ... are breathing and can alert medical caregivers ... the amount of carbon dioxide the patient ...
(Date:7/10/2014)... July 10, 2014 /PRNewswire-iReach/ -- Tute Genomics, ... today announced an agreement with Lineagen, Inc., ... Lineagen,s NextStep Dx PLUS.  Lineagen, focused ... neurological disorders, currently offers FirstStep Dx ... service used by healthcare providers as a ...
(Date:7/10/2014)... 15, 2014 -- According to the International Atomic ... security comes from terrorists acquiring sufficient quantities of ... a crude nuclear explosive device. The IAEA also ... have involved gram-level quantities, which can be challenging ... to a new study appearing this week in ...
(Date:7/10/2014)... the journal PNAS (Proceedings of the National Academy ... and sleep deprivation have a significant effect on our ... the best time of day to test for diseases ... medicines effectively. , Researchers from the University of Surrey ... links between sleep deprivation, body clock disruption and metabolism, ...
Breaking Biology Technology:Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 3Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 4Sensitive detection method may help impede illicit nuclear trafficking 2Time of day crucial to accurately test for diseases, new research finds 2
... April 5, 2011 Embryo Donation International ... facilities in the United States, officially opened today to ... globe desiring to build a family.     ... mission is to reduce the number of frozen ...
... YORK, April 5, 2011 Reportlinker.com announces that ... its catalogue: DNA Sequencing - ... http://www.reportlinker.com/p0203540/DNA-Sequencing---technologiesmarkets-and-companies.html This report briefly ... sequencing technologies, and their applications. Current large and ...
... PITTSBURGH, April 5, 2011 Mylan Inc. (Nasdaq: ... subsidiary Bioniche Pharma has launched Octreotide Acetate Injection ... Novartis, Sandostatin®, a treatment for a rare hormonal ... used to suppress or inhibit severe diarrhea associated ...
Cached Biology Technology:A New Company Is Born - Embryo Donation International 2Reportlinker Adds DNA Sequencing - Technologies, Markets and Companies 2Mylan Launches Generic Version of Sandostatin® 2
(Date:7/11/2014)... Salk Institute for Biological Studies, BGI, and other ... and reliability of the existing targeted gene correction ... which could significantly increased gene-correction efficiency in human ... online in Cell Stell Cell provides ... therapy. , The combination of stem cells and ...
(Date:7/11/2014)... Researchers have pioneered a revolutionary new way ... called Virtual Finger, allows scientists to move through ... synapses using the flat surface of their computer ... studies orders of magnitude more efficient, saving time, ... many areas of experimental biology. The software and ...
(Date:7/11/2014)... the normal circumstances, astrocytes participate in normal ... and exhibit therapeutic and repairing effects on ... have found that nerve cells differentiated from ... reduced viability, which produces influences on subsequent ... General Hospital, Hebei United University, China demonstrated ...
Breaking Biology News(10 mins):A new genome editing method brings the possibility of gene therapies closer to reality 2Virtual finger enables scientists to navigate and analyze complex 3D images 2
... Scientists have known for some time that throwing off ... In fact, workers whose sleep-wake cycles are disrupted by ... such as diabetes, obesity and cancer. Researchers at ... a possible molecular link between circadian rhythm disturbances and ...
... Aug. 1 by scientists at Cold Spring Harbor Laboratory ... Meier-Gorlin syndrome (MGS) with specific cellular dysfunctions that are ... of dwarfism, small brain size, and other manifestations of ... Although only 53 cases of Meier-Gorlin syndrome have been ...
... team of researchers, including scientists from Wits University, have substantially ... of modern culture, all thanks to the San people of ... from South Africa, France, Italy, Norway, the USA and Britain, ... journal, Proceedings of the National Academy of Sciences , ...
Cached Biology News:Scientists discover molecular link between circadian clock disturbances and inflammatory diseases 2Scientists discover molecular link between circadian clock disturbances and inflammatory diseases 3Protein involved in DNA replication, centrosome regulation linked to dwarfism, small brain size 2Protein involved in DNA replication, centrosome regulation linked to dwarfism, small brain size 3Protein involved in DNA replication, centrosome regulation linked to dwarfism, small brain size 4Modern culture 44,000 years ago 2Modern culture 44,000 years ago 3
Mouse monoclonal antibody raised against a partial recombinant PASK. NCBI Entrez Gene ID = PASK...
Agarose II (Low Melt)...
...
... I can be used in intracellular staining ... cells and to serve as an antibody ... cell permeabilization is a reversible process, it ... the presence of saponin during intracellular staining. ...
Biology Products: